Start-Up Nation Finder

45 companies were selected

Add smartlist note (optional)

Smartlist name*

Smartlist must have a valid name.

Description (optional)

Hey #USER_FULLNAME#!

Claim #COMPANY_NAME# ’s profile to become an administrator with editing privileges in
#COMPANY_NAME# ’s page on Start-Up Nation Finder

The invitation to claim the profile was originally sent to

Hey #USER_FULLNAME#!

Claim #COMPANY_NAME# ’s profile to become an administrator with editing privileges in
#COMPANY_NAME# ’s page on Start-Up Nation Finder

Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

Name*

Work Email* (please provide your email in the organization)

Position*

Notes

I agree to receive Informational Emails from Start-Up Nation Finder as defined in the Privacy Policy and Terms of Use

Already have an account?

Search Was Saved

Home > Companies > IR-MED

Claimed by owner • Last Update 27.6.2022 • Suggest Edits • Claim Profile

Claimed by owner

IR-MED

Noninvasive Infrared-based Diagnostics

Public on OTCQB Dec, 2020

IR-MED

www.globenewswire.com • Aug 30, 2022

IR-Med Signs Agreement for the Commercial Design of the PressureSafe Device

www.globenewswire.com • Aug 12, 2022

IR-Med files Provisional Patent Application Covering Additional Features of its PressureSafe Device for Early Detection of Pressure Injuries

www.globenewswire.com • Jun 23, 2022

IR-Med To Initiate Useability Study of its PressureSafe Device

www.businesswire.com • May 10, 2022

IR-MED Names Moshe Gerber as New CEO

www.businesswire.com • Apr 14, 2022

IR-Med Announces $3.2 Million Private Placement

www.globenewswire.com • Nov 12, 2021

IR-Med to Become Fully Reporting SEC Company

www.globenewswire.com • Apr 8, 2021

IR-Med, Inc. Announces the Resignation of Limor Davidson Mund as CEO and Appointment of Chairman of the Board Oded Bashan as Interim Chief Executive Officer

www.globenewswire.com • Jan 20, 2021

IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to "IRME"

www.globenewswire.com • Dec 29, 2020

INTERNATIONAL DISPLAY ADVERTISING, INC. ANNOUNCES COMPLETION OF REVERSE MERGER AND CLOSING OF $2.2 MILLION PRIVATE PLACEMENT

www.globenewswire.com • Dec 15, 2020

INTERNATIONAL DISPLAY ADVERTISING, INC AND IR MED LTD EXTEND OUTSIDE DATE OF SECURITIES EXCHANGE AGREEMENT

www.globenewswire.com • Sep 23, 2020

International Display Advertising, Inc and ir Med Ltd Agree to Securities Exchange Agreement

www.globenewswire.com • Mar 9, 2020

International Display Advertising, Inc. Announces Letter of Intent to Merge with IR Med Ltd.

IR-MED is developing a noninvasive spectrographic analysis technology platform that allows healthcare professionals to detect and measure different molecules in human blood and tissue in real time, without any invasive procedures.

The company’s first product under development is a handheld optical monitoring device designed to support the early detection of pressure injuries to the skin and underlying tissue, regardless of skin tone. The device is calibrated specifically to each patient’s skin in order to detect pressure injuries caused primarily by prolonged pressure associated with bed confinement.

By providing highly accurate, noninvasive readings, IR-MED’s personalized medical devices offer caregivers an optimal decision-support system for complex cases.